The OPEX has taken a bit of a hit.
Scoping study...….A$108m incl reagents consumables A$35.7m
PFS....……………….A$154m incl power, gas and consumables A$71m
Also revenue of A$40.4m for Hematite has me scratching my head, any ideas.
- Forums
- ASX - By Stock
- PM1
- Ann: PFS confirms strong business case for TECH Project
Ann: PFS confirms strong business case for TECH Project, page-21
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PM1 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online